Louise Campbell and Roger Green interview Stephen Harrison as part of our year-end series for 2022, our last individual interview with Stephen.
Panelists reflecting on Stephen Harrison share what they consider his most important and lasting professional accomplishments.
Panelists reflect on their personal memories of Stephen Harrison
Panelists share some of their favorite “Harrisonisms” – unique phrases and verbal memes from Stephen Harrison.
Colleagues and friends Manal Abdelmalek and Naim Alkhouri join the Surfers in the first of what will be several conversations remembering our co-founder, the SLD master Stephen Harrison.
On April 23, SurfingMASH Co-founder Stephen Harrison passed away unexpectedly. This episode starts with panelists each sharing a memory of Stephen.
This week’s vault episode looks back to last September, when Laurent Castera joined the Surfers to discuss different roles that NITs can play in MASH drug development and patient assessment.
This final conversation about MASH drug development includes continued discussion of combination therapies and a discussion on NITs’ vital role in speeding the process and making it more efficient.
Sven Francque and William Alazawi join the Surfers discuss the impact of concomitant metabolic therapies like incretin agonists on MASH Drug Development.
Sven Francque and William Alazawi join the Surfers to discuss challenges in creating efficacy endpoints, and also areas where development has improved since 2020during MASH Drug Development.
